Generalizability of Randomized Trial Results to Target Populations: Design and Analysis Possibilities

被引:50
|
作者
Stuart, Elizabeth A. [1 ]
Ackerman, Benjamin [1 ]
Westreich, Daniel [2 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[2] Univ N Carolina, Chapel Hill, NC USA
关键词
literature review; evidence-based practice; EXTERNAL VALIDITY; TRANSPORTABILITY; IMPACT;
D O I
10.1177/1049731517720730
中图分类号
C916 [社会工作、社会管理、社会规划];
学科分类号
1204 ;
摘要
Randomized trials play an important role in estimating the effect of a policy or social work program in a given population. While most trial designs benefit from strong internal validity, they often lack external validity, or generalizability, to the target population of interest. In other words, one can obtain an unbiased estimate of the study sample average treatment effect from a randomized trial; however, this estimate may not equal the target population average treatment effect if the study sample is not fully representative of the target population. This article provides an overview of existing strategies to assess and improve upon the generalizability of randomized trials, both through statistical methods and study design, as well as recommendations on how to implement these ideas in social work research.
引用
收藏
页码:532 / 537
页数:6
相关论文
共 50 条
  • [41] ASSESSING THE GENERALIZABILITY OF RANDOMIZED EVIDENCE BY COMPARING RESULTS FROM A CLINICAL TRIAL AND ESTABLISHED QUALITY IMPROVEMENT COLLABORATIVE: RESULTS FROM G-MINOR AND MUSIC
    Singhal, Udit
    Jiang, Ralph
    Spratt, Daniel E.
    Schipper, Matthew
    Salami, Simpa S.
    Daignault-Newton, Stephanie
    Dunn, Rodney
    Maatman, Thomas J.
    Lane, Brian R.
    Burks, Frank N.
    Rodriguez, Paul
    Kleer, Eduardo
    Sarle, Richard
    Feng, Felix Y.
    Cher, Michael L.
    Dess, Robert T.
    Morgan, Todd M.
    JOURNAL OF UROLOGY, 2023, 209 : E590 - E590
  • [42] Extending Randomized Trial Estimates to Different Target Populations: An Application to a Nested Trial Comparing Anticoagulant Regimens for Percutaneous Coronary Intervention
    Young, Jessica C.
    Dahabreh, Issa J. J.
    Erlinge, David
    James, Stefan
    Frobert, Ole
    Berglund, Anita
    Hernan, Miguel A.
    Matthews, Anthony A.
    Rylance, Rebecca
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 107 - 108
  • [43] Target-specific randomized discontinuation trial design: a novel approach in molecular therapeutics
    Galsky, Matthew D.
    Zaks, Tal
    Hassani, Habib
    Vocila, Linda
    Sonpavde, Guru
    Hutson, Thomas E.
    Von Hoff, Daniel D.
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (02) : 194 - 198
  • [44] Biomarker-based Bayesian randomized clinical trial design for identifying a target population
    Sugitani, Yasuo
    Morita, Satoshi
    Nakakura, Akiyoshi
    Yamamoto, Hideharu
    STATISTICS IN MEDICINE, 2023, 42 (16) : 2797 - 2810
  • [45] Target-specific randomized discontinuation trial design: a novel approach in molecular therapeutics
    Matthew D. Galsky
    Tal Zaks
    Habib Hassani
    Linda Vocila
    Guru Sonpavde
    Thomas E. Hutson
    Daniel D. Von Hoff
    Investigational New Drugs, 2010, 28 : 194 - 198
  • [46] Generalizability of Results from Randomized Controlled Trials in Post-Stroke Physiotherapy
    Paci, Matteo
    Prestera, Claudia
    Ferrarello, Francesco
    PHYSIOTHERAPY CANADA, 2020, 72 (04) : 382 - 393
  • [47] Incentive Design for Ad-Sponsored Content Results from a Randomized Trial
    Sen, Soumya
    Burtch, Gordon
    Gupta, Alok
    Rill, Rudiger
    2017 IEEE CONFERENCE ON COMPUTER COMMUNICATIONS WORKSHOPS (INFOCOM WKSHPS), 2017, : 826 - 831
  • [48] Sequential design and analysis in the randomized clinical trial: A historical perspective
    Rosenberger, William F.
    SEQUENTIAL ANALYSIS-DESIGN METHODS AND APPLICATIONS, 2020, 39 (03): : 295 - 306
  • [49] Design and Analysis Considerations for a Sequentially Randomized HIV Prevention Trial
    Benkeser, David
    Horvath, Keith
    Reback, Cathy J.
    Rusow, Joshua
    Hudgens, Michael
    STATISTICS IN BIOSCIENCES, 2020, 12 (03) : 446 - 467
  • [50] Design and Analysis Considerations for a Sequentially Randomized HIV Prevention Trial
    David Benkeser
    Keith Horvath
    Cathy J. Reback
    Joshua Rusow
    Michael Hudgens
    Statistics in Biosciences, 2020, 12 : 446 - 467